While the COVID-19 pandemic is interrupting access to some healthcare services, an innovative approach may hold the key to support for those with low back pain. Researchers at the University of Sydney and the Kolling Institute have launched a study to measure the effectiveness of a mobile health program which offers self-management strategies via text messages. Study lead Professor Manue.....
Read more

Regeneus, a clinical-stage regenerative medicine company, has announced an exciting research collaboration with Professor Christopher Little and the Raymond Purves Bone and Joint Research Laboratory at the Kolling Institute. The study will further explore the disease modifying effects of Progenza™ and assess its effect in modulating the inflammatory and immune responses in a pre-cl.....
Read more

Congratulations to Professor David Hunter who’s been announced as a finalist for Research Australia’s annual Health and Medical Research Awards. The prestigious awards celebrate the outstanding achievements of individuals and teams who drive innovative health and medical research. They aim to recognise excellence across the sector, and encourage future generations of researchers. Profess.....
Read more

New research has found that while the majority of Australian spinal surgeons expect large improvements from common spinal procedures, they say there is only poor quality scientific evidence demonstrating the effectiveness of surgery compared with non-surgical approaches like physiotherapy. A team from the Kolling Institute’s Back Pain Research group and the University of Sydney sur.....
Read more

Kolling researchers are part of an international team calling for musculoskeletal health to become a global priority, addressing a current lack of funding for the world’s leading cause of pain. The project team found the management of musculoskeletal health is under-prioritised despite its impact on the community, and devised an action plan to address this gap. Led by Professors An.....
Read more

New funding announced by the Federal Government will see researchers from the Kolling Institute and the University of Sydney drive an international study to determine the best treatment for those with knee cartilage damage. More than $1 million dollars has been awarded through a collaborative research grant scheme involving Australia’s National Health and Medical Research Council and the.....
Read more

Kolling researcher Professor Lyn March will lead a large, collaborative national trial to improve treatments and outcomes for those with disabling rheumatoid and psoriatic arthritis. Federal Government MRFF funding will see more than $2.7 million invested in the project which will involve 400 participants across the country. Professor March, who is also the head of the Department of Rheu.....
Read more

With many of us looking to adopt a healthier lifestyle, researchers say a new approach may not only deliver benefits for your heart and waistline but may reduce low back pain as well. The condition affects one in six Australians or four million people and is the leading cause of adult musculoskeletal pain worldwide. Researchers from the University of Sydney and the Kolling Institute have.....
Read more

Kolling researcher Professor David Hunter will lead one of the world’s largest clinical trials into the effectiveness of stem cell therapy for those with knee osteoarthritis. More than 400 participants will be recruited for the SCUlpTOR study which will see trial sites established at Royal North Shore Hospital and the Menzies Institute in Hobart. Professor Hunter, the Florance and Cope .....
Read more

The base of our thumb may just be a small part of our hand, but osteoarthritis in that area can have a significant impact, making the simplest tasks difficult. The condition especially affects post-menopausal women, with figures indicating up to a third of women over 70 have this type of osteoarthritis. Increasing numbers of people are experiencing the condition, and yet current treatme.....
Read more